Investor Alert: Robbins LLP Informs Stockholders of the Intellia Therapeutics, Inc. Class Action

SAN DIEGO, Feb. 12, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Intellia Therapeutics, Inc. (NASDAQ: NTLA) securities between June 30, 2024 and January 28, 2025. Intellia describes itself as a leading clinical-stage gene editing company, focused on developing potentially curative therapeutics using CRISPR/Cas9-based technologies.For more information, submit a form, email attorney Aaron Dumas, Jr., or give ...